400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2020-06-10
针对癌症的生物构建体研发商
医药研发/制造
Sectoral Asset Management;
Sectoral Asset Management;
Omega Funds;
Omega Funds;
BrightEdge Ventures;
Sofinnova Partners;
VenBio Partners;
Clough Capital Partners;
Medixci;
诺和诺德;
F-Prime Capital;
德诚资本;
Longitude Capital
生物天使2026-01-25
广州医科大学附属第二医院2026-01-25
晨哨并购2026-01-24
动脉橙果局2026-01-24
蒲公英Ouryao2026-01-24
Antibody Research2026-01-24
医药云端工作室2026-01-24
精准药物2026-01-24
医药笔记2026-01-24
生物天使2026-01-24